Share Name Share Symbol Market Type Share ISIN Share Description
Genedrive Plc LSE:GDR London Ordinary Share GB00B1VKB244 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  7.00 29.17% 31.00 30.50 31.50 31.75 25.25 26.125 7,031,425 11:57:48
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.7 -1.9 -1.2 - 28

Genedrive Shares Rise After Start of FDA Process for MT-RNR1 Product Range

05/10/2022 8:53am

Dow Jones News

Genedrive (LSE:GDR)
Historical Stock Chart

From Jul 2022 to Jan 2023

Click Here for more Genedrive Charts.

By Kyle Morris


Shares in Genedrive PLC rose 15% on Wednesday after the company said that it has begun the process for regulatory approval for its MT-RNR1 ID Kit with the U.S. Food and Drug Administration.

The molecular-diagnostics company said the MT-RNR1 assay is a rapid point-of-care test to screen infants in urgent care for a genetic variant that could cause life-long hearing loss when carriers are given certain antibiotics.

Shares in Genedrive at 0721 GMT were up 1.60 pence at 12.60 pence.


Write to Kyle Morris at


(END) Dow Jones Newswires

October 05, 2022 03:38 ET (07:38 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

1 Year Genedrive Chart

1 Year Genedrive Chart

1 Month Genedrive Chart

1 Month Genedrive Chart
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20230127 12:22:35